Interleukin Genetics Inc.
135 Beaver Street
Waltham,
MA 02452
United States - Map
Phone: 781-398-0700
Fax: 781-398-0720
Web Site: http://www.ilgenetics.com
| Interleukin Genetics, Inc., together with its subsidiaries, focuses on developing, acquiring, and commercializing personalized health products that help individuals improve and maintain their health through preventive measures in the United States and internationally. It conducts, researches, develops, markets, and sells genetic test panels primarily in inflammatory and metabolic areas to provide insight into health, wellness, and disease. The company markets and distributes genetic tests under the GENSONA brand, through a strategic partnership with Alticor; and PST tests through sales and marketing partners to dentists and periodontists. It offers genetic tests for periodontal disease risk assessment, cardiovascular risk assessment, and general nutrition assessment. The company has research collaborations with the University of Sheffield, Tufts University, New York University, Harvard University, the Mayo Clinic, California Pacific Medical Center, Boston University, the University of Arkansas, Tongji Medical College, University of North Carolina, and Yonsei University. Interleukin Genetics, Inc. was founded in 1986 and is headquartered in Waltham, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Lewis H. Bender , 50
Chief Exec. Officer |
$
427.00K | N/A | Dr. Kenneth Kornman D.D.S., PH.D., 61
Founder, Pres, Chief Scientific Officer, Sec. |
$
338.00K |
$
38.00K | Mr. Eliot M. Lurier CPA, 51
Chief Financial Officer, Principal Accounting Officer and Treasurer |
$
198.00K | N/A | Ms. Patricia D. Murphy Ph.D., FACMG,
Consultant - ClIA-certified DNA Laboratory |
N/A
| N/A | Mr. Todd Anthony Walker ,
VP of Marketing |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.03% Nasdaq 0.00%
Profile
